OAZ grows 40% in 2025 and expands partnership with Paramount Pictures to bring SpongeBob to exclusive experiences
The brand is a partner of the new film and reinforces its licensing strategy to win over consumers
São Paulo, December 2025 - OAZ, Eurofarma's personal care brand, in partnership with Paramount Pictures, presents throughout the month of December a robust set of initiatives to expand the presence of the SpongeBob character in retail and online and offline media, driven by the launch of the film "SpongeBob SquarePants: Search for SquarePants," which premieres on December 25 in theaters throughout Brazil.
Since 2023, OAZ has already had an exclusive line of children's sun protection that features the character on the packaging, offering a playful experience for children. The brand has been gaining more and more space in pharmaceutical retail. According to August 2025 data from Close-Up, in just two years OAZ is already the second player with the largest expansion of market share in Brazil in the mass sun protection category.
"Eurofarma has greatly expanded its operations in the OTC market, which has giant growth potential for the coming years. We want to be part of this movement and we strongly believe that our OAZ brand, especially in the sun protection category, can play a prominent role, with partnerships that bring connection and innovative experiences to consumers," comments Donino Scherer, Director of OTC and Generics at Eurofarma.
This is the first time Eurofarma has carried out an exclusive partnership in cinema. Both in the premiere and in all regular sessions, the company displays the OAZ institutional trailer. In addition, the brand, in partnership with Cinemark, has prepared Instagrammable spaces of the OAZ SpongeBob universe at the São Paulo (Shopping Eldorado) and Rio de Janeiro (Shopping Downtown) units, where the public can take photos and interact with the brand. As an additional benefit, Cinemark Club members will have access to an exclusive 35% discount on the oaz.vc website.
As part of the activations, OAZ will have a special action in Rio de Janeiro, with a themed store in partnership with a local pharmacy chain, and the ‘Buy and Get’ campaign, held in partnership with Ingresso.com, which offers benefits to the consumer and expands the brand's visibility within the platform.
Expansion in OTC
Eurofarma's OTC division has stood out since 2021, with strategic acquisitions and launches that expanded its presence in categories such as oral health, personal care, supplements, and food. In 2024 alone, the OTC unit as a whole grew 23.5%, reaching more than R$ 430 million in revenue. In addition to OAZ, brands like Valda and Fixaderme are already references in the market and are part of the company's growth strategy, which seeks to offer complete solutions for health and well-being.
In November, the company's OTC portfolio was further strengthened with the launch of Rehidrat, its new high-performance isotonic line, developed to offer fast and effective hydration in different consumption situations.
About Eurofarma
Founded in 1972, Eurofarma operates in the health sector with the production and marketing of products and services to improve people's quality of life. With a focus on generating shared value, it covers the main pharmaceutical segments, such as medical prescription, generics, hospital, oncology, OTC, personal care, and animal health, in addition to providing production services to third parties. With broad coverage of therapeutic classes, the portfolio comprises more than 4,000 SKUs, serving practically all medical specialties. Leader in medical prescription in Brazil, where it also holds the vice-leadership in generics, Eurofarma is present in 24 countries, with 100% coverage in Latin America and leadership in the region's retail. It also maintains operations in the USA and Africa, counting in total more than 13.5 thousand employees and 11 factories, and accounted for 600 million units produced in 2024. In the same year, the company invested more than R$ 800 million in innovation projects and achieved net revenue exceeding R$ 11 billion.
Press Information
G&A Relações Públicas
Iza França - 11 97644-4496 (iza.franca@gaspar.com.br)
Murillo Israel (murillo.israel@gaspar.com.br)
Anne Ikehara (anne.ikehara@gaspar.com.br)
Guilherme Gaspar - 11 98285-6000